Announcement • Aug 18
Argo Graphene Solutions Corp. announced that it expects to receive CAD 1 million in funding Argo Graphene Solutions Corp. announces a non brokered private placement to issue 1,000,000 Units at an issue price of CAD 1 for an aggregate gross proceeds of CAD 1,000,000 on August 17, 2026. Each Unit will consist of one common share of the Company and one common share purchase warrant with each Warrant entitling the holder to acquire one additional common share at an exercise price of CAD 1.20 for a period of one year from the date of issuance. The securities issued pursuant to the Offering will be subject to a statutory four-month hold period from the date of issuance. The Offering will have an over-allotment option for up to an additional 200,000 Units for additional gross proceeds of up to CAD 200,000, exercisable at the Company's discretion. Closing of the Offering is subject to receipt of all necessary approvals, including acceptance by the Exchange. The Company may pay
finder's fees in connection with the Offering in accordance with applicable securities laws and the policies of the Canadian Securities Exchange. Announcement • Jul 17
Argo Graphene Solutions Corp. Announces CEO Changes Argo Graphene Solutions Corp. announced the appointment of Dr. Vikas Berry as Chief Executive Officer of the Company. Dr. Berry succeeded Mr. Sean McAlpine, who had served as Interim Chief Executive Officer since June 2026.Mr. McAlpine remains a Director of the Company and continues to play an important role supporting Argo's strategic growth initiatives. Dr. Berry's appointment marks a defining milestone in Argo's evolution as the Company aims to advance from technology acquisition to commercialization. As the inventor of the proprietary STREAM™ graphene production platform, he is uniquely qualified to lead Argo as it works towards executing its strategy to commercialize the technology under the Company's previously announced exclusive worldwide licence agreement, which includes a pathway to full ownership of the STREAM™ technology and related intellectual property upon satisfaction of the agreed consideration provisions. Sean McAlpine, who has served as Interim Chief Executive Officer since the closing of the Company’s previously announced exclusive worldwide license agreement with Grapherry Inc. continues to serve as a Director of the Company. Dr. Berry is an internationally recognized graphene scientist, inventor, entrepreneur, and founder of Grapherry Inc., where he developed the proprietary STREAM™ graphene production platform. Over the past two decades, his work has focused on developing scalable, cost-effective manufacturing technologies designed to advance graphene from scientific research into real-world industrial applications. Dr. Berry is committed to progressing the STREAM™ platform towards commercialization and executing a vision of building a vertically integrated graphene production and commercialization company serving multiple global industries. Board Change • Jul 02
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. President & Independent Director Scott Smale was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 
